MicroRNA silencing in primates: towards development of novel therapeutics

Andreas Petri1, Morten Lindow, Sakari Kauppinen

  • 1Santaris Pharma, Kogle Allé 6, Hørsholm, Denmark and Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, Copenhagen, Denmark.

Cancer Research
|January 17, 2009
PubMed

Insights

Small noncoding RNAs called microRNAs (miRNAs) regulate genes and are implicated in cancer. Antisense oligonucleotides offer a promising strategy for developing miRNA-based cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression posttranscriptionally.
  • Aberrant miRNA expression is increasingly recognized for its role in human cancers.
  • miRNAs represent potential therapeutic targets for cancer treatment.

Purpose of the Study:

  • To explore the therapeutic potential of targeting microRNAs in cancer.
  • To highlight the utility of antisense oligonucleotides for miRNA silencing in cancer therapy.

Main Methods:

  • Utilizing chemically modified antisense oligonucleotides.
  • Investigating high-affinity targeting of microRNAs.
  • Evaluating miRNA silencing in preclinical models (rodents and nonhuman primates).

Main Results:

  • Demonstrated efficient silencing of microRNAs using modified antisense oligonucleotides.
  • Showcased the effectiveness of this approach in animal models.
  • Highlighted the potential for developing miRNA-based cancer therapeutics.

Conclusions:

  • Chemically modified antisense oligonucleotides are effective tools for miRNA silencing.
  • This approach holds significant promise for the development of novel miRNA-based cancer therapeutics.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...